Superior long-term survival with acceptable safety of ATG/G-CSF–based haplo-HSCT with intensified BU+MEL/TT conditioning in CR Pediatric Non-DS–AMKL - Quiz - MDSpire

Superior long-term survival with acceptable safety of ATG/G-CSF–based haplo-HSCT with intensified BU+MEL/TT conditioning in CR Pediatric Non-DS–AMKL

  • By

  • Fei Pan

  • Jing Long

  • Xing-yu Cao

  • Yue Lu

  • Jian-ping Zhang

  • Yan-li Zhao

  • Min Xiong

  • Fang-min Pan

  • Guan-lan Yue

  • Kang Gao

  • Zhi-jie Wei

  • April 30, 2026

  • 0 min

Share

Original Source(s)

Superior long-term survival with acceptable safety of ATG/G-CSF–based haplo-HSCT with intensified BU+MEL/TT conditioning in CR Pediatric Non-DS–AMKL

  • by Fei Pan, Jing Long, Xing-yu Cao, Yue Lu, Jian-ping Zhang, Yan-li Zhao, Min Xiong, Fang-min Pan, Guan-lan Yue, Kang Gao, Zhi-jie Wei

  • April 30, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma